Events

  • 3rd Annual Immunogenicity and Tolerance Seminar

    Posted on August 30, 2017 by Katie Porter
    It’s a Dutch Treat! The 3rd Annual Immunogenicity and Tolerance Seminar November 9th, 2017 View Event Photos! This ​meeting ​will ​focus ​on ​the ​determinants ​of ​immunogenicity ​– ​a ​key ​feature ​of ​effective ​vaccines ​and ​a ​key ​barrier ​to ​success ​in ​the ​clinic ​for ​protein ​therapeutics. ​Conversely, ​tolerance ​induction ​is ​a ​key ​feature ​of ​successful ​protein ​therapeutics, ​while ​suppressing ​immune ​responses ​to ​vaccines. ​The ​reduction ​of ​T ​cell ​epitopes ​and ​introduction ​of ​Treg ​epitopes ​(like ​Tregitopes) ​for ​protein ​therapeutics, ​and ​the ​reverse ​process ​for ​vaccines, ​will ​be ​discussed ​and ​illustrated ​in ​case ​studies. ​ Enjoy engaging presentations, case studies and discussions with speakers to include Dr. Annie ​De ​Groot, MD (EpiVax CEO), Wim ​Jiskoot, ​PhD (Leiden ​Academic ​Centre for Drug Research), Vincent ​Lombardi, ​PhD (Stallergenes), Ab ​Osterhaus, DVM ​PhD (University ​of ​Veterinary ​Medicine ​in ​Hannover, ​Germany), Bram ​Slütter, ​PhD (Leiden ​University) and Jagadeesh ​Bayry, DVM PhD (Institut ​National ​de ​la ​Santé ​et ​de ​la ​Recherche ​Médicale ​(INSERM) ​Unité), Julien Karrich, PhD (Sanquin), and Eduardo Guillen, PhD (EpiVax). Food, refreshments and cocktail hour to ...
    Read more
  • Westin Seminar 2017 (Tokyo)

    Posted on August 25, 2017 by Steven Vessella
    View Event Photos! The Westin Immunogenicity Seminar is a unique forum for industry and academic professionals to share ideas, present research updates and network with potential collaborators.  The purpose of this seminar is to bridge the gap between protein drug development and recent academic research on Tregs, Tregitopes, with a special focus on immunogenicity, deimmunization and ...
    Read more
  • 2017 Computational Vaccinology Workshop at International Society of Vaccines

    Posted on August 21, 2017 by Katie Porter
    View Event Photos! iCubed ​and EpiVax will ​be ​hosting ​a ​workshop ​in ​vaccine ​design ​and ​Computational ​Vaccinology, ​to ​be ​held ​at ​the ​Institut ​Pasteur ​in ​Paris, ​France on October 4th, 2017. Students ​and ​researchers ​will ​have ​the ​opportunity ​to ​learn ​about the state-of-the-art iVAX ​informatics ​toolkit ​and ​how ​it ​may ​be ​applied ​to ​rapidly ​develop ​vaccines. Topic areas include malaria, neglected and emerging infectious diseases (NTD/EID), cancer vaccines, and computational vaccine (CV) design methods.  Participants ​will ​hear ​from ​speakers ​who ​have ​used ​the ​iVAX ​toolkit ​to ​identify ​epitopes ​and ​design ​vaccines ​in ​real-time. Speakers include Annie De Groot, M.D. (URI/Epivax); Rogerio Amino, Ph.D. (Institut Pasteur); Pietro Bertino (University of Hawaii Cancer Center); Frances Terry ...
    Read more
  • Fearless Science at BIO2017

    Posted on May 19, 2017 by Steven Vessella
    EpiVax will be in San Diego at the BIO international Convention, the most influential biotech convention in the industry. Look for us in the partnering system to arrange a meeting! After hours, we are hosting a networking reception at Puesto (Tuesday 20th, 7:00pm-9:30pm). Come unwind with us and enjoy Mexico’s best handcrafted items to eat and drink. We look forward to seeing you! Where: Puesto ...
    Read more
  • Spring Is Here and EpiVax is Improving Human Health Everywhere

    Posted on April 14, 2017 by Katie Porter
    Those of us on the U.S. East Coast are happy to say farewell to winter – Spring is Here! And EpiVax is springing up everywhere! Join us at the following events to learn more about immunogenicity, influenza vaccines, personalized cancer vaccines and more! UPCOMING EVENTS IVW 2017 Conference April 19-21, Lausanne At the sixth international conference and exhibition focusing on ‘Influenza Vaccination Issues’  Dr. ...
    Read more
  • 5th Annual NTD/EID Workshop

    Posted on February 20, 2017 by Annie De Groot
    5th Annual NTD/EID Computational Vaccinology Workshop May 15th – 19th, 2017 iCubed, 80 Washington Street  Providence RI, United States   The Institute for Immunology and Informatics (iCubed) will once again be hosting our training workshop in vaccine design for Neglected Tropical Diseases and Emerging Infectious Diseases (NTD/EID) This May, the Institute for Immunology and Informatics (iCubed) will once again be hosting a training workshop in ...
    Read more
  • EpiVax at Bio Asia 2017

    Posted on February 20, 2017 by Annie De Groot
    Lucky us! the 14th International Bio Asia Conference is scheduled for March 14-15, 2017 at the Grand Hyatt, Tokyo in Roppongi. It might be a bit early for cherry blossoms, but hope springs eternal! We will be arriving a bit early and staying a bit late. Please let us know if you would like us to meet with you ...
    Read more
  • Update: Screening for Immunogenicity: Immunotherapy Challenges and Predictive Approaches Applied to Therapeutic Proteins 

    Posted on February 3, 2017 by Katie Porter
    Update: This event has been cancelled by the organizers. Thank you for your interest. As an expert in immunogenicity screening, EpiVax’s CEO/CSO, Dr. Annie De Groot, will be conducting a training on state of the art methods of in silico and in vitro analysis to assess immunogenic risk of therapeutic proteins. Please join us April 5th in Lyon to ...
    Read more
  • Creating Locally, Thinking Globally

    Posted on December 16, 2016 by Katie Porter
    EpiVax is now a member of Eurobiomed , a community bringing together scientific thought leaders with a common mission: Improve the health of all and as  quickly as possible. EpiVax, as a key player in the development of immunotherapies, will be in attendance at the B2B match event for Preclinical Development of Immunotherapies organized by Eurobiomed and MabDesign in ...
    Read more
  • 9th Annual Biotech Showcase

    Posted on December 8, 2016 by Katie Porter
    Join us at Biotech Showcase! Partnering opportunities are available! Click Here to schedule. Get leading-edge information on our latest immunoinformatics platform: An Innovative Computational Pipeline for Personalized Cancer Vaccine Design With superior identification of neo-antigens, EpiVax is using our validated vaccine design tools to accelerate the advancement of next generation of cancer immunotherapeutics.
    Read more
  • Bio-Europe Spring

    Posted on December 8, 2016 by Katie Porter
    EpiVax will be joining more than 1,400 companies from over 45 countries at Bio-Europe Spring, the premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in Europe’s most innovative biopharma clusters. Partner with us to hear about our new immunoinformatics platform accelerating the advancement of personalized cancer vaccine design. Partnering is ...
    Read more
  • Immunogenicity and Tolerance Seminar (updated)

    Posted on June 28, 2016 by Steven Vessella
    UPDATE: Here are commemorative photos from our event. Thank you to all the speakers and participants for making the 2016 seminar a success. See you next year! Click to see full image EpiVax has taken the lead on the 2nd seminar on Immunogenicity and Tolerance on October 24th, 2016. The conference agenda is shown below. What: Immunogenicity and Tolerance Seminar When: Monday, October 24th, ...
    Read more
  • Westin Tokyo Immunogenicity Seminar 2016 (Updated)

    Posted on May 5, 2016 by Steven Vessella
    UPDATE: Here are commemorative photos from our event. Thank you to all the speakers and participants for making the 2016 seminar a success. See you next year!   —- The 7th annual Westin Tokyo Immunogenicity Seminar is set for October 17th, 2016. The Westin Immunogenicity Seminar is a unique forum for industry and academic professionals to share ideas, give research ...
    Read more
  • Westin Tokyo Immunogenicity Seminar 2016

    Posted on May 5, 2016 by Steven Vessella
    Register Here The 7th annual Westin Tokyo Immunogenicity Seminar is set for October 17th, 2016. The Westin Immunogenicity Seminar is a unique forum for industry and academic professionals to share ideas, give research updates and network with potential collaborators.  The purpose of this seminar is to bridge the gap between protein drug development and recent academic research on ...
    Read more
  • Fearless Science 2016

    Posted on May 1, 2016 by Steven Vessella
    Fearless Science BIO-International Networking Reception Tuesday June 7th, 2016 San Francisco, CA Mourad Restaurant 5:30-8:30 pm We all know partnering is a main reason to attend the BIO conventions. So we are keeping it going into the night, with our annual Fearless Science event at BIO-International! Join Annie and Steven after the workday at Mourad Restaurant, just a short walk or cab ride ...
    Read more
  • Antibody Industrial Symposium

    Posted on April 29, 2016 by Steven Vessella
    The 4th Antibody Industrial Symposium will bring together antibody companies, scientific researchers, clinicians and technology suppliers to discuss current and next generation antibody formats. A carefully assembled scientific committee has set-up an exciting program with keynote lectures, pitch talks on new creative projects, and industrial talks from the pharmaceutical industry. EpiVax’s Annie De Groot will join the list of speakers  at this ...
    Read more
  • Immunogenicity and Tolerance Seminar (updated)

    Posted on April 28, 2016 by Steven Vessella
    Platine and EpiVax are co-organizing their 2nd seminar on Immunogenicity and Tolerance on October 24th, 2016. The conference agenda is shown below. Click this link to register This meeting will focus on the determinants of immunogenicity – a key feature of effective vaccines and a key barrier to success in the clinic for protein therapeutics. Conversely, tolerance induction is a key feature of successful protein therapeutics, ...
    Read more
  • Modern Vaccines Adjuvants Formulation 2016

    Posted on April 13, 2016 by Steven Vessella
    EpiVax will be presenting ‘Pathogen Camouflage: Implications for Vaccine Design’ at the Modern Vaccines Adjuvants Formulation (MVAF) taking place on 18-20 May 2016 in Copenhagen. MVAF 2016 will be the fifth meeting in this conference series and will offer an international forum for the discussion of all aspects of vaccine and adjuvant formulation. The conference will focus on: Innovation in ...
    Read more
  • A New Milestone – Save the Date!

    Posted on April 11, 2016 by Steven Vessella
    After 9 years of successful organization of a highly respected international vaccine conference series in collaboration with Elsevier, ISV will become the sole organizer starting in 2016. With the same format and content as in previous 9 years, ISV will be fully responsible for the scientific organization and business management of the meeting, including the selection of ...
    Read more
  • NTD/EID Vaccine Design Training, May 2016

    Posted on April 10, 2016 by Annie De Groot
    From May 23rd-27th, the Institute for Immunology and Informatics (iCubed) will once again host a workshop in vaccine design for neglected tropical diseases and emerging infectious diseases (NTD/EID). This self-funded, annual workshop has been created to give interested researchers an opportunity to work one-on-one with the developers of the iVAX toolkit, developed by EpiVax and now available for research ...
    Read more
  • AAPS Biotechnology Conference May 2016

    Posted on February 29, 2016 by Annie De Groot
    http://www.aaps.org/nationalbiotech/
    Read more
  • BioEurope Spring 2016

    Posted on February 29, 2016 by Annie De Groot
    We’re off to Stockholm for BIO-Europe Spring (BES2016), which will take place 4–6 April in Stockholm, Sweden. We will be joining international leaders from biotech, pharma and finance to identify and enter new strategic relationships. Sign up to meet us now through the partnering system or via email
    Read more
  • EpiVax at Bio Asia 2016

    Posted on February 29, 2016 by Annie De Groot
    Lucky us! the 13th International Bio Asia Conference is scheduled for March 15-16, 2016 at the Grand Hyatt, Tokyo in Roppongi. It might be a bit early for cherry blossoms, but hope springs eternal! We will be arriving a bit early and staying a bit late. Please let us know if you would like us to meet with you ...
    Read more
  • Are we ready for the Immunology Revolution?

    Posted on December 31, 2015 by Steven Vessella
      EpiVax  hosted an exciting JP Morgan Healthcare Conference Event: a panel discussion by expert alumni and friends of the University of Chicago, on new immune therapies (checkpoint inhibitors and personalized cancer vaccines). This event featured a panel with: Moderator: Alexander Johns (College 83, Booth ’87) and Panelists: Anne De Groot (Pritzker ’83, EpiVax), of Robert Ang, (Neon Therapeutics), ...
    Read more
  • EpiVax at the EpiCenter of RI Commerce

    Posted on November 18, 2015 by Steven Vessella
    On Wednesday November 18th, EpiVax CIO/COO Bill Martin welcomed Rhode Island Governor Gina Raimondo, Secretary of Commerce Stefan Pryor and Providence Mayo Jorge Elorza to EpiVax headquaters for a press conference to announce the latest Innovation Initiatives for small businesses in the state. The event was live tweeted @EpiVax_BD. Governor Gina Raimondo is focused on enhancing business growth ...
    Read more
  • Yale & CURE BioHaven presents ‘Vaccine Pipelines 2015’

    Posted on October 20, 2015 by Steven Vessella
    VACCINES 2015 – Building Pipelines to Serve Unmet Medical Needs And Target Commercial Opportunity Wednesday, October 28 4:00 pm – 6:00 pm Anlyan Center at Yale 300 Cedar Street New Haven, CT 06519 Details and Registration This Yale & CURE BioHaven event assembles experts from 4 companies to trade business stories and share their thinking about how to position and sell vaccines ...
    Read more
  • EpiVax to Present at 52nd IBRCC Meeting

    Posted on October 5, 2015 by Steven Vessella
    EpiVax will present the latest information about Stealth Botox at the upcoming Interagency Botulism Research Coordinating Committee (IBRCC) meeting in Frederick, Maryland. IBRCC is an annual national and international forum for presenting state-of-the-art research on botulinum toxin and the deadly disease it causes, botulism. The fundamental purpose of IBRCC is to provide a mechanism for coordination ...
    Read more
  • 9th Vaccine Renaissance: Last Call for Abstracts

    Posted on September 11, 2015 by Katie Porter
    ONE MORE DAY TO SUBMIT YOUR ABSTRACT! 9th Vaccine Renaissance Conference Providence, RI – November 4-6, 2015 The 9th Annual Vaccine Renaissance Conference planning committee is pleased to invite you to submit an abstract for consideration. This year the focus will be on new methods that will improve vaccine efficacy and safety and on the crucial role ...
    Read more
  • Where in the World is EpiVax?

    Posted on August 11, 2015 by Katie Porter
    Having a hard time keeping up with the EpiVaxer’s?   Click HERE for more information about where we will be in September & October! October 15th → Taipei, Taiwan •Thursday, October 15th: 1st annual Westin Taipei Immunogenicity Seminar (FREE!). Click HERE to register. October 17th-24th → Seoul, Korea •Saturday, October 17th: Computational Vaccinology Workshop (CV5) at 9th Vaccine & ISV Annual ...
    Read more
  • Westin Immunogenicity Seminar comes to Taipei! (Updated)

    Posted on July 21, 2015 by Katie Porter
    EpiVax’s 1st annual Westin Taipei Immunogenicity Seminar is coming to Taiwan! Update: The Westin Taipei Immunogenicity Seminar took place on October 15th and the room was nearly filled to capacity. The inaugural seminar in Taiwan was a great success and our audience was very pleased with the event outcome. We are already thinking about our next event ...
    Read more
  • EpiVax Tokyo Fall visit – Westin Immunogenicity Seminar (Updated)

    Posted on June 25, 2015 by Katie Porter
    Announcing the date for EpiVax’s annual Westin Immunogenicity Seminar. Update: The Westin Tokyo Immunogenicity Seminar took place on September 14th. We are already thinking about our next event in Tokyo which will coincide with the Japanese College of Rheumatology Annual Scientific Meeting in April 2016. Special thanks to our speakers for bringing their exciting work to seminar . Please enjoy commemorative ...
    Read more
  • Westin Immunogenicity Seminar, Daejeon – October 2015

    Posted on June 23, 2015 by Steven Vessella
    The Westin Immunogenicity Seminar Daejeon is scheduled on the 22nd of October. Sign up now to attend! Last year’s speakers included: Dr. Sung-Joo Lee (State of Biotechnology in S. Korea), Head of Research, Sanofi Asia Pacific R&D, Dr. Katy Park (Cancer Vaccines), Korea University College of Medicine, and Dr. Annie De Groot, CEO/CSO, EpiVax and Director and Professor, University of Rhode Island ...
    Read more
  • 5th Computational Vaccinology Workshop (CV5) at ISV

    Posted on June 1, 2015 by Annie De Groot
    We invite you to join us for this year’s iteration of the Computational Vaccinology Workshop @ ISV. Register for this event! Abstract submissions for full-length papers and posters are still being accepted – submit your abstracts now. The 5th Computational Vaccinology Workshop at International Society for Vaccines (CV5 @ ISV) is a satellite workshop to be held Saturday, October 17th ...
    Read more
  • Fearless Science @Bio 2015

    Posted on May 28, 2015 by Steven Vessella
    Fearless Science comes to BIO International Wednesday, June 17th, Philadelphia, PA 7-9:30 pm XIX Restaurant 200 South Broad Street Philadelphia, PA 19102 Annie, Kelsey and Steven will be partnering all day long and… relaxing at night above the Hyatt at The Bellevue at XIX Restaurant! Just a short walk or cab ride from the Pennsylvania Convention Center. We would love ...
    Read more
  • Lyon Seminar: Immunogenicity Determinants and Tolerance

    Posted on May 14, 2015 by Katie Porter
    EpiVax and Platine Pharma Services are co-organizing our first international appointment of industries and academic scientists to exchange knowledge about Immunogenicity Determinants and Tolerance. For the first time in Lyon, France, we would be pleased if you would join us to meet experts and develop networking opportunities on immunogenicity topics. This free, one-day seminar is being ...
    Read more
  • URI Accepting Fellows for NTD Vaccine Design Toolkit and Training Workshop Set for May 2015

    Posted on March 29, 2015 by Anthony Marcello
    PROVIDENCE, R.I. – March 26, 2015 – The University of Rhode Island’s Institute for Immunology and Informatics is currently accepting fellows to participate in a workshop and training course targeting neglected tropical diseases (NTD) and emerging infectious diseases (EID). The workshop will focus on training NTD/EID researchers interested in using new vaccine design tools developed by Principal ...
    Read more
  • Westin Immunogenicity Seminar Seoul – April 2015

    Posted on March 28, 2015 by Annie De Groot
    UPDATE: April 28th, 2015. Here are the slides that EpiVax presented at the seminar: Vaccine Design Using in Silico Tools (6.4MB) Immunogenicity Screening and Epitope Engineering (6.3MB) We had a great time in Seoul and we hope you did also! Thank you for your participation and engagement. If you have any questions please email info@epivax.com for a prompt reply. We hope to ...
    Read more
  • Gordon Research Conference – Tropical Infectious Diseases

    Posted on March 4, 2015 by Katie Porter
    March 8-13 Galveston, Texas EpiVax will be attending the 2015 Gordon Research Conference on “Tropical Infectious Diseases” from March 8th-13th. Dr. Lenny Moise will present “Immunoinformatics: New Platforms for Vaccine Target Discovery”. Participants will have an opportunity to attend an afternoon workshop (March 11 from 2-4pm) at University of Texas Medical Branch to receive hands-on training in ...
    Read more
  • BIO-Europe Spring

    Posted on March 4, 2015 by Katie Porter
    March 9-11 Paris, France Partner with us at BIO-Europe Spring! EpiVax will be returning to this “must attend” event for getting business done in the biotech industry. We will be joining international leaders from biotech, pharma and finance to identify and enter new strategic relationships. Sign up to meet us now through the partnering system or ...
    Read more
  • URI Hosts TRIAD Workshop on Neglected and Emerging Infectious Diseases

    Posted on November 18, 2014 by Katie Porter
    Translational Immunology Research and Accelerated Development program (TRIAD) We would like to invite you to apply to the TRIAD workshop on Neglected and Emerging Infectious Disease Vaccines Design Toolkit & Training. The workshop will be held for two weeks from January 5-16, 2015 at the Institute for Immunology and Informatics (iCubed) at the University of ...
    Read more
  • Antigen Specific Tolerance Induction at Immunogenicity Summit Nov 19 2014

    Posted on November 18, 2014 by Annie De Groot
    Why is antigen-specificity key for biologics?  Annie De Groot, MD, CEO and CSO of EpiVax will be speaking at the CHI Immunogenicity summit on this topic, November 19th at 3 PM. It’s well known that tolerance can be induced by powerful transplant drugs but combining those powerful agents with biologics would not be generally acceptable (certainly not ...
    Read more
  • The Story-Telling-Cloth – Or how we use Textiles as Social Media to improve Vaccine Uptake

    Posted on November 4, 2014 by Annie De Groot
    GAIA Vaccine Foundation’s Story-Telling Cloth receives “Grand Challenges Explorations Grant” Award For West African-Style “Social Media” Cervical Cancer Prevention Campaign Providence, Rhode Island, 04 November 2014. The Bill and Melinda Gates Foundation awarded $100,000 to GAIA Vaccine Foundation to test whether dissemination of a printed cloth that tells the story of HPV, coupled with a media campaign ...
    Read more
  • Senator Whitehouse

    Senator Whitehouse, Homeland Security Headline Vaccine Renaissance Conference

    Posted on October 14, 2014 by Annie De Groot
    Senator Whitehouse (RI) addressed more than 100 experts in the field of vaccine development today at the 8th Vaccine Renaissance, an annual event organized by the University of Rhode Island’s Institute for Immunology and Informatics and supported by EpiVax. He stated that it was tragic that the Sequester achieved what it set out to do – to be a ...
    Read more
  • 8th Vaccine Renaissance October 13-16 2014

    Posted on October 8, 2014 by Annie De Groot
    Vaccine experts to gather in Providence as fight against deadly diseases carries on   Providence, R.I. – October 8, 2014 – As many African countries as well as the United States continue to grapple with the outbreak of Ebola and other deadly diseases, the University of Rhode Island is getting ready to play host to some of ...
    Read more
  • Puesto Party Tonight!

    Posted on June 24, 2014 by Anthony Marcello
    Join us for the EpiVax and Platine BIO 2014 party tonight starting 7 pm at Puesto in San Diego. Food and drinks will be provided by EpiVax and our good friends at Platine Pharma Services. You don’t want to miss this event! If you cannot make it to the Puesto event and would still like to ...
    Read more
  • CV4 Submission Deadline Extended!

    Posted on June 24, 2014 by Anthony Marcello
    We are pleased to announce an extension of the deadline to submit full-length papers to the 4th Computational Vaccinology Workshop. The deadline, originally July 1st will be extended to August 4th.  The deadline for poster abstracts is August 25th. Hopefully this extra time will allow you to polish your submissions to this exciting workshop. For more details ...
    Read more
  • Dr. Leslie Cousens to Speak at CRS Novozymes Workshop

    Posted on June 11, 2014 by Anthony Marcello
    Albumin: The Next Generation Protein Therapeutic Cosponsored by Novozymes Biopharma Inc. About the Workshop Saturday, July 12, 08:45 – 17:00 Organizers: Kenneth Howard, Aarhus University, Denmark, and Daniel Shelly, Novozymes Biopharma US, Inc., U.S.A. Albumin is the most abundant human plasma protein that exhibits prolonged circulatory half-life and a predominant role in extracellular and intracellular transport of nutrients. Exploitation of these ...
    Read more
  • EpiVax at SMi Immunogenicity Conference in London

    Posted on June 10, 2014 by Anthony Marcello
    Dr. Anne De Groot will be a Keynote Speaker at the SMI’s inaugural conference on Immunogenicity, taking place in London on July 14th and 15th. The SMi Conference brochure and agenda can be found here. Here is some information about Dr. De Groot’s Keynote Presentation on  July 14th at 11:00 am: Tregitopes an Immunomodulation Powerhouse: Regulating Immune Responses to ...
    Read more
  • EpiVax at BIO San Diego

    Posted on May 30, 2014 by Anthony Marcello
    EpiVax will be attending this year’s BIO International Convention in San Diego June 23-26. BIO International is the world’s largest biotechnology gathering and we are always looking to learn more about the frontiers of the biotechnology industry. Annie De Groot and Anthony Marcello will be attending and participating in partnering meetings. If you would like to meet for a ...
    Read more
  • 5 New EpiVax Posters at AAPS 2014 in San Diego

    Posted on May 14, 2014 by Anthony Marcello
    EpiVax is attending the 2014 AAPS National Biotechnology Conference, in beautiful San Diego.  We will be presenting 5 new posters (see posters below). Also, come pick up some EpiVax schwag at our table! Brand New EpiVax Posters: Regulating Immune Responses to Biologics: Validation of Screening, Deimmunization and Tolerization Approaches – May 2014 Tolerization as a Rational Design Approach for Reducing the Immunogenicity ...
    Read more